DaehanPharmaceutical operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DaehanPharmaceutical with three other
companies in this sector in South Korea:
Kolon Life Science Incorporation
sales of 118.10 billion Korean Won [US$104.64 million]
of which 59%
was Environment Material),
CKD Bio Corp
(118.19 billion Korean Won [US$104.71 million]
of which 100%
was Pharmaceutical Manufacturing), and
Ctc Bio, Incorporation.
(130.56 billion Korean Won [US$115.68 million]
of which 71%
was Animal Medication).
DaehanPharmaceutical reported sales of 144.44 billion Korean Won (US$127.97 million)
December of 2017.
increase of 3.6%
versus 2016, when the company's sales were 139.44 billion Korean Won.
Sales at DaehanPharmaceutical have increased during each of the previous five years
(and since 2012, sales have increased a total of 50%).